SC Filed 2019-07-12 Event — SEC 0000903423-19-000289 →

VIKING GLOBAL INVESTORS LP → Myovant Sciences Ltd.

Stake: — Shares: —

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

19 13D/G filings on this issuer

18 other filings besides this one

Filer Track Record

22 filings by this filer

21 other filings in the data moat

Short Interest

—

Not in latest FINRA snapshot

Other 13D/G Filings on Myovant Sciences Ltd.

Filed	Form	Filer	Stake	Shares
2022-10-24	SC	Sumitomo Chemical Co., Ltd.	—	—	view →
2022-10-03	SC	Sumitomo Chemical Co., Ltd.	—	—	view →
2021-10-27	SC	Sumitomo Chemical Co., Ltd.	—	—	view →
2021-09-17	SC	Sumitomo Chemical Co., Ltd.	—	—	view →
2021-05-17	SC	Sumitomo Chemical Co., Ltd.	—	—	view →
2020-05-15	SC	Sumitomo Chemical Co., Ltd.	—	—	view →
2020-04-16	SC	Sumitomo Chemical Co., Ltd.	—	—	view →
2020-03-26	SC	Sumitomo Chemical Co., Ltd.	—	—	view →
2020-03-18	SC	Sumitomo Chemical Co., Ltd.	—	—	view →
2019-12-31	SC	Roivant Sciences Ltd.	—	—	view →
2019-07-17	SC	Lo Andrew	—	—	view →
2019-07-17	SC	Machado Patrick	—	—	view →
2019-07-16	SC	Roivant Sciences Ltd.	—	—	view →
2019-07-12	SC	SVF Investments (UK) Ltd	—	—	view →
2019-07-12	SC	QVT Financial LP	—	—	view →
2019-07-12	SC	Dexxon Holdings Ltd.	—	—	view →
2019-06-05	SC	SVF Investments (UK) Ltd	—	—	view →
2018-04-04	SC	SVF Investments (UK) Ltd	—	—	view →

Other Filings by VIKING GLOBAL INVESTORS LP

Filed	Form	Issuer	Stake	Shares
2026-07-10	SCHEDULE 13D/A	BridgeBio Pharma, Inc. BBIO	5.00%	9,792,219	view →
2026-06-12	SCHEDULE 13D	STANDARD BIOTOOLS INC. LAB	15.00%	58,651,170	view →
2026-05-18	SCHEDULE 13G	Artiva Biotherapeutics, Inc. ARTV	—	—	view →
2026-04-02	SCHEDULE 13D/A	BridgeBio Pharma, Inc. BBIO	6.10%	11,842,434	view →
2025-07-01	SCHEDULE	BridgeBio Pharma, Inc. BBIO	9.80%	18,602,920	view →
2025-01-31	SCHEDULE	BridgeBio Pharma, Inc. BBIO	11.70%	22,055,375	view →
2023-11-07	SC	Cazoo Group Ltd	—	—	view →
2023-09-22	SC	Cazoo Group Ltd	—	—	view →
2023-07-20	SC	BridgeBio Pharma, Inc. BBIO	—	—	view →
2023-04-27	SC	Cazoo Group Ltd	—	—	view →
2023-02-27	SC	Cazoo Group Ltd	—	—	view →
2022-03-04	SC	Ginkgo Bioworks Holdings, Inc. DNABW	—	—	view →
2021-10-01	SC	Ginkgo Bioworks Holdings, Inc. DNABW	—	—	view →
2019-07-12	SC	Arbutus Biopharma Corp ABUS	—	—	view →
2019-07-12	SC	Urovant Sciences Ltd.	—	—	view →
2019-07-12	SC	Axovant Gene Therapies Ltd.	—	—	view →
2019-03-19	SC	Axovant Sciences Ltd.	—	—	view →
2019-01-03	SC	Axovant Sciences Ltd.	—	—	view →
2019-01-03	SC	Urovant Sciences Ltd.	—	—	view →
2019-01-03	SC	Arbutus Biopharma Corp ABUS	—	—	view →

Showing 20 of 21

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →